Trial intelligence / Profile preview

Phase 2a AeroDerm in Adults with Atopic Eczema

2005-002077-76Phase 2Completed

Sponsor
Aerovance
Start
May 2005
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, single-arm trial of pitrakinra in atopic dermatitis (AD), sponsored by Aerovance. Primary endpoint: Change in Eczema Area and Severity Index (EASI) score. Started May 2005; status: completed.

02

Drugs

pitrakinra
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on 2005-002077-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002077-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call